Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like Medovex Corporation Retains CG Capital As Investor Relations Counsel April 13, 2017 Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges August 29, 2017 Therachon Appoints Biotechnology Leader As Chief Medical Officer August 28, 2017